Snehal Patel
CEO and CFO at Greenwich LifeSciences Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Greenwich LifeSciences Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Greenwich LifeSciences Inc. December 18, 2025100.0%
-
Greenwich LifeSciences Inc. December 19, 2024100.0%
-
Greenwich LifeSciences Inc. December 15, 2023100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 29, 2026 | Greenwich LifeSciences Inc. | Open-market purchase | +700 | $13.10 | $9,170 |
| Jul 28, 2026 | Greenwich LifeSciences Inc. | Open-market purchase | +1,500 | $13.59 | $20,385 |
| Jul 27, 2026 | Greenwich LifeSciences Inc. | Open-market purchase | +1,500 | $13.62 | $20,430 |
| Jul 24, 2026 | Greenwich LifeSciences Inc. | Open-market purchase | +1,100 | $12.88 | $14,168 |
| Jul 23, 2026 | Greenwich LifeSciences Inc. | Open-market purchase | +2,500 | $13.14 | $32,850 |
| Jan 13, 2026 | Greenwich LifeSciences Inc. | Open-market purchase | +1,800 | $29.83 | $53,694 |
| Jan 12, 2026 | Greenwich LifeSciences Inc. | Open-market purchase | +2,900 | $27.54 | $79,866 |
| Dec 31, 2025 | Greenwich LifeSciences Inc. | Open-market purchase | +4,300 | $21.36 | $91,848 |
| Dec 30, 2025 | Greenwich LifeSciences Inc. | Open-market purchase | +2,900 | $21.73 | $63,017 |
| Dec 18, 2025 | Greenwich LifeSciences Inc. | Open-market purchase | +4,100 | $12.62 | $51,742 |
| Nov 25, 2025 | Greenwich LifeSciences Inc. | Open-market purchase | +4,600 | $8.37 | $38,502 |
| Nov 7, 2025 | Greenwich LifeSciences Inc. | Open-market purchase | +10,600 | $8.43 | $89,358 |
| Oct 31, 2025 | Greenwich LifeSciences Inc. | Open-market purchase | +2,300 | $9.26 | $21,298 |
| Apr 25, 2025 | Greenwich LifeSciences Inc. | Open-market purchase | +3,600 | $9.88 | $35,568 |
| Apr 17, 2025 | Greenwich LifeSciences Inc. | Open-market purchase | +5,400 | $8.98 | $48,492 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.